Sustained disease remission after spontaneous HBeAg seroconversion is associated with reduction in fibrosis progression in chronic hepatitis B Chinese patients (Q80752603)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 September 2007

Language	Label	Description	Also known as
English	Sustained disease remission after spontaneous HBeAg seroconversion is associated with reduction in fibrosis progression in chronic hepatitis B Chinese patients	scientific article published on 01 September 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17680649%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Sustained disease remission after spontaneous HBeAg seroconversion is associated with reduction in fibrosis progression in chronic hepatitis B Chinese patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17680649%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

based on heuristic

inferred from title

chronic hepatitis B

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

Chee-Kin Hui

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17680649%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Nancy Leung

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17680649%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Tony W H Shek

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17680649%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Hung Yao

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17680649%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Wai-Ki Lee

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17680649%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Jak-Yiu Lai

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17680649%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Sik-To Lai

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17680649%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Wai-Man Wong

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17680649%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Lawrence S W Lai

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17680649%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Ronnie T P Poon

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17680649%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Chung-Mau Lo

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17680649%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Sheung-Tat Fan

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17680649%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

George K K Lau

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17680649%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Hong Kong Liver Fibrosis Study Group

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17680649%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

language of work or name

0 references

publication date

1 September 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17680649%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17680649%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

46

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17680649%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17680649%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

690-698

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17680649%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver transplantation and hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history and prognosis of hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon-alpha for HBeAg-positive chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B e antigen and the risk of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history of patients with recurrent chronic hepatitis C virus and occult hepatitis B co-infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

Fibrosis progression in chronic hepatitis C patients with occult hepatitis B co-infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II dose-escalating trial of clevudine in patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

Histological grading and staging of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of fibrosis progression in chronic liver diseases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic area.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

Predicting cirrhosis risk based on the level of circulating hepatitis B viral load

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison in the progression of liver fibrosis in chronic hepatitis C between persistently normal and elevated transaminase

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes of interferon and ribavirin treatment for chronic hepatitis C in patients with normal serum aminotransaminases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

A long-term follow-up study on hepatitis B surface antigen-positive patients undergoing allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

An appraisal of the histopathological assessment of liver fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

Histological grading and staging in chronic hepatitis: clinical applications and problems

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21758

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.21758

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17680649%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17680649%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80752603&oldid=2216379091"